Page last updated: 2024-08-17

tubercidin and Reperfusion Injury

tubercidin has been researched along with Reperfusion Injury in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, X; Chen, J; Fan, L; Liu, P; Qiu, S; Xu, Y; Yu, L; Zhang, M; Zhang, X1
Chiang, CH; Perng, WC; Wu, CP; Yan, HC; Yu, CP1

Other Studies

2 other study(ies) available for tubercidin and Reperfusion Injury

ArticleYear
EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke.
    European journal of pharmacology, 2019, Aug-15, Volume: 857

    Topics: Animals; Apoptosis; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Reperfusion Injury; STAT3 Transcription Factor; Tubercidin; Up-Regulation

2019
Use of anti-(tumour necrosis factor-alpha) antibody or 3-deaza-adenosine as additives to promote protection by University of Wisconsin solution in ischaemia/reperfusion injury.
    Clinical science (London, England : 1979), 2000, Volume: 99, Issue:3

    Topics: Adenosine; Allopurinol; Animals; Antibodies, Monoclonal; Glutathione; Hemodynamics; Insulin; Lung; Lung Transplantation; Male; Organ Culture Techniques; Organ Preservation; Organ Preservation Solutions; Organ Size; Raffinose; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tubercidin; Tumor Necrosis Factor-alpha

2000